Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function.

The pharmacokinetics of metioprim, a new competitive inhibitor of bacterial dihydrofolate reductases, were studied after a single oral dose of 100 mg in two young healthy subjects, four elderly volunteers, and eight patients with impaired renal function. The pharmacokinetic parameters of unchanged m...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Vergin, H, Bishop-Freudling, G B, Kaiser, W, Köhler, M, Strobel, K, Reutter, F W
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1983
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185136/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6638987/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.2.190
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!